CD52-directed Cytolytic Antibody

Alemtuzumab contraindicated conditions:

Alemtuzumab desired effects:

  • Increased Lymphocyte Cell Destruction

Alemtuzumab drug classes:

  • CD52-directed Cytolytic Antibody

Alemtuzumab pharmacologic actions:

  • Antineoplastic Agents, Immunological

Alemtuzumab mechanism of action:

  • Antibody-Receptor Interactions
  • CD52-directed Antibody Interactions
  • treatable

The content offered on is intended for informational purposes only and not as medical advice. For medical advice you should consult an appropriately licensed and qualified medical professional. If you are experiencing acute or distressing symptoms or life threatening symptoms you should immediately call 911 and/or go to the nearest emergency medical facility.

Copyright © Treatable 2022
Last updated: 1/27/2022, 11:53:41 AM